I wish these guys drafted their comms better. You had to read it very carefully to see the 60% full year growth forecast. Particularly when this Half revenue at 30m is down on last quarter (35.2)!
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025